about
Signal transduction inhibitors in treatment of myelodysplastic syndromesSystematically studying kinase inhibitor induced signaling network signatures by integrating both therapeutic and side effectsEfficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors.Benzo[e]pyridoindoles, novel inhibitors of the aurora kinases.Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner.CDC25A(Q110del): a novel cell division cycle 25A isoform aberrantly expressed in non-small cell lung cancerThe PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancerEmerging Roles of Branched-Chain Amino Acid Supplementation in Human Diseases.Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?Role of mTOR inhibitor in cholangiocarcinoma cell progression.Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells.A1E inhibits proliferation and induces apoptosis in NCI-H460 lung cancer cells via extrinsic and intrinsic pathways.PIK3CA gene mutation associated with poor prognosis of lung adenocarcinomaAssociations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study.
P2860
Q26829903-F4686192-18D9-4822-A3A0-D7902D01D148Q28536170-0A26963E-1F4E-4357-81FE-D0B145F1EC03Q33385120-55E05D5B-B100-4BD0-AD57-8969AEBC6D99Q33409814-B485DB50-22A1-42B6-8D3B-9B9C2F5B8305Q33709957-56FC0F5F-EE6A-4356-9B6C-1528DFE9B9ADQ34447183-3D6D1C58-B109-45D1-BA59-EE2181BCF12DQ35680138-29338CCF-0E09-40C0-B1A4-EF941EF6D33EQ36356958-6DFCD834-6FAB-4B0A-85C7-42A677E4AE9EQ36979805-13D181EC-5F8B-4082-B851-65B601E3DEABQ37760357-080318B8-AEF1-44FF-8DB4-DF0E258E1310Q39023980-6037C98A-F115-400A-924E-2D3EFBB2E67EQ39106999-EB591E3A-CA43-4181-86B5-F2B21074F4E0Q39155402-BF22B9E0-82B7-4EF5-BE38-30A88CA3301CQ40656200-2B55C2BD-58C7-432D-8D35-8965290E9A7AQ55005077-95DF7DC2-A8BD-4598-B581-27F6F05E9A01
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
New targets for non-small-cell lung cancer therapy.
@en
type
label
New targets for non-small-cell lung cancer therapy.
@en
prefLabel
New targets for non-small-cell lung cancer therapy.
@en
P2093
P2860
P1476
New targets for non-small-cell lung cancer therapy.
@en
P2093
Edgardo S Santos
Eloy Roman
Luis E Raez
Manrique Alvarez
P2860
P304
P356
10.1586/14737140.7.10.1423
P577
2007-10-01T00:00:00Z